49 results on '"Khattak H"'
Search Results
2. OC18 Is it safe to diagnose coeliac disease using the no-biopsy pathway for those with TGA-IgA ≥5x upper limit of normal: a regional study from Southwest England?
- Author
-
Gangalam, V, primary, Basude, D, additional, Khattak, H, additional, Knight, C, additional, Tashtoush, L, additional, Broad, S, additional, Zurick, N, additional, and Paul, S, additional
- Published
- 2023
- Full Text
- View/download PDF
3. Corrigendum to “043 The pediatric and adolescent training in obstetrics and gynecology in Europe” [Eur. J. Obstet. Gynecol. Reprod. Biol. 273 (2022) E16–E17]
- Author
-
Boekhorst, F., primary, Topçu, E.G., additional, Horala, A., additional, Khattak, H., additional, and Henriques, M. Gonçalves, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis
- Author
-
Khattak, H, Malhas, R, Craciunas, L, Afifi, Y, Amorim, CA, Fishel, S, Silber, S, Gook, D, Demeestere, I, Bystrova, O, Lisyanskaya, A, Manikhas, G, Lotz, L, Dittrich, R, Colmorn, LB, Macklon, KT, Hjorth, IMD, Kristensen, SG, Gallos, I, Coomarasamy, A, Khattak, H, Malhas, R, Craciunas, L, Afifi, Y, Amorim, CA, Fishel, S, Silber, S, Gook, D, Demeestere, I, Bystrova, O, Lisyanskaya, A, Manikhas, G, Lotz, L, Dittrich, R, Colmorn, LB, Macklon, KT, Hjorth, IMD, Kristensen, SG, Gallos, I, and Coomarasamy, A
- Abstract
BACKGROUND: Ovarian tissue cryopreservation involves freezing and storing of surgically retrieved ovarian tissue in liquid or vapour nitrogen below -190°C. The tissue can be thawed and transplanted back with the aim of restoring fertility or ovarian endocrine function. The techniques for human ovarian tissue freezing and transplantation have evolved over the last 20 years, particularly in the context of fertility preservation in pre-pubertal cancer patients. Fresh ovarian tissue transplantation, using an autograft or donor tissue, is a more recent development; it has the potential to preserve fertility and hormonal function in women who have their ovaries removed for benign gynaecological conditions. The techniques of ovarian tissue cryopreservation and transplantation have progressed rapidly since inception; however, the evidence on the success of this intervention is largely based on case reports and case series. OBJECTIVE AND RATIONALE: The aim of this study was to systematically review the current evidence by incorporating study-level and individual patient-level meta-analyses of women who received ovarian transplants, including frozen-thawed transplant, fresh or donor graft. SEARCH METHODS: The review protocol was registered with PROSPERO (CRD42018115233). A comprehensive literature search was performed using MEDLINE, EMBASE, CINAHL and Cochrane Central Register of Controlled Trials from database inception to October 2020. Authors were also contacted for individual patient data if relevant outcomes were not reported in the published manuscripts. Meta-analysis was performed using inverse-variance weighting to calculate summary estimates using a fixed-effects model. OUTCOMES: The review included 87 studies (735 women). Twenty studies reported on ≥5 cases of ovarian transplants and were included in the meta-analysis (568 women). Fertility outcomes included pregnancy, live birth and miscarriage rates, and endocrine outcomes included oestrogen, FSH and LH levels. Th
- Published
- 2022
5. 97. Experiences of young girls and women undergoing ovarian tissue cryopreservation: a systematic review and thematic synthesis
- Author
-
Khattak, H., primary, Woodman, H., additional, Coomarasamy, A., additional, Topping, A., additional, and Gallos, I., additional
- Published
- 2022
- Full Text
- View/download PDF
6. 36 Feasibility and safety of short stay hysterectomy
- Author
-
Antoun, L., primary, Smith, P., additional, Afifi, Y., additional, Clark, T., additional, and Khattak, H., additional
- Published
- 2022
- Full Text
- View/download PDF
7. 211 Surgical sperm retrieval (SSR) for management of azoospermia: 1 Year report from a tertiary fertility centre (UK)
- Author
-
Khattak, H., primary, Banjoko, A., additional, Kuhakumaran, M., additional, Moti, Z., additional, and Chu, J., additional
- Published
- 2022
- Full Text
- View/download PDF
8. IMPELLA 2.5: TIME FOR A MORATORIUM?: 091
- Author
-
Samani, P., Arcenas, R., Khattak, H., Hahn, H., and Schwartz, B.
- Published
- 2015
9. O-178 Reproductive and endocrine outcomes after fresh and frozen-thawed ovarian tissue transplantation based on age and anti-cancer therapy: A systematic review and individual patient data meta-analysis
- Author
-
Khattak, H, primary, Malhas, R, additional, Craciunas, L, additional, Afifi, Y, additional, Fishel, S, additional, Amorim, C, additional, Gallos, I, additional, and Coomarasamy, A, additional
- Published
- 2021
- Full Text
- View/download PDF
10. Effect of Metformin Therapy on Clinical and Hormonal Indices of Patients with Polycystic Ovary Syndrome
- Author
-
Inayat, S., primary, Khattak, H. F., additional, Muhammad, M. G., additional, Robeen, K., additional, Inayat, A., additional, and ., Fatima, additional
- Published
- 2021
- Full Text
- View/download PDF
11. Poster display II clinical general
- Author
-
Gurgenyan, S. V. Svetlana, Vatinyan, S. K. H., Nikogosyan, K. G., Edilyan, L. B., Chobanyan, B. G., Lacourcière, Y., Marcel Dumont, M., Lefebvre, J., Poirier, L., Côté, C., Peix, A. Amalia, Alonso, O., Chae, I. H., Chung, J. K., Gutierrez, C., Kropp, J., Onsel, C., Silvasi, I., Llerena, L., Padhy, A. K., Garcia-Barreto, D., Trapaga, A., Asen, L., Infante, O., Ponce, F., Cabrera, L. O., Valiente, J., Tornes, F., Guerrero, I., Zayas, R., ones, M. A. Quin, Castro, J., Fayad, Y., Carrillo, R., Paz, A. De, Mehlsen, J. Jesper, Hædersdal, C., Daou, D. Doumit, Benada, A., Lebtahi, R., Idy-Peretti, I., Guludec, D. Le, Coaguila, C., Vilain, D., Leenhardt, A., Heinicke, N. Norbert, Benesch, B., Kaiser, T., Seegmüller, M., Schönberger, J., Eilles, C., Riegger, G. A. J., Holmer, S., Luchner, A., Kouris, N. T. Nikos, Kontogianni, D. D., Goranitou, G. S., Sifaki, M. D., Kalkandi, E. M., Grassos, H. E., Papoulia, E., Babalis, D. K., Moralidis, E. Efstratios, Spyridonidis, T., Arsos, G., Karakatsanis, K., Karatzas, N., Parameswaran, R. V. Ramanathapuram, Sundaram, P. S. Palaniswamy Shanmuga, Padma, S., Haridas, K. K., Zachariah, M., Kumar, S., Feola, M. Mauro, Leonardi, G., Peano, S., Bianchi, A., Dutto, P., Guala, E., Biggi, A., Uslenghi, E., Filardi, P. Pasquale Perrone, Pace, L., Dellegrottaglie, S., Corrado, L., Cafiero, M., Camerino, R., Maglione, A., Polimeno, M., Zarrilli, A., Chiariello, M., Giorgetti, A. Assuero, Gimelli, A., Marini, C., Schluter, M., Kusch, A., D’Aragona, I., Marzullo, P., Gimelli, A. Alessia, Stanislao, M., Zanco, P., Inglese, E., Bertelli, P., Valle, G., Tassone, F., Pepino, R., Francini, A., Garrone, O., Occelli, M., Merlano, M., Florimonte, L. Luigia, Pagani, L., Piatti, L., Butti, I., Maffioli, L. S., Casorelli, E., Dottore, F. Del, Gentili, G., Agostini, M., Pieri, P. L. Pierluigi, Milan, E., Giubbini, R. Raffaele, Mazzanti, M. Marco, Serenelli, M., Perna, G. P., Ferro, A., Duilio, C., Santomauro, M., Salvatore, M., Cuocolo, A. Alberto, Bertagna, F., Bosio, G., Terzi, A., Paghera, B., Kaneta, T. Tomohiro, Otani, H., Hakamatsuka, T., Fukuda, H., Nakazato, R. Ryo, Moroi, M., Kunimasa, T., Furuhashi, T., Sugi, K., Yasuhi, W. Watanabe, Akihiro, S., Yukawa, A., Ryu, K., Kimio, T., Yasuhiko, T., Nariaki, E., Yasunori, W., Akashi, Y. J. Yoshihiro, Musha, H., Kida, K., Itoh, K., Inoue, K., Kawasaki, K., Hashimoto, N., Nakazawa, K., Miyake, F., Fukuzawa, S. Shigeru, Ozawa, S., Inagaki, M., Sugioka, J., Okino, S., Matsuo, S. Shinro, Matsumoto, T., Nakae, I., Masuda, D., Horie, M., Mori, Y. Yoshitomo, Takahashi, K., Masai, M., Kawasaki, D., Kanemori, T., Okuda, S., Tanabe, K., Ohyanagi, M., Takahashi, K. Keiko, Masai, M., Mori, Y., Tanabe, K., OKuda, S., Toyama, T. Takuji, Hoshizaki, H., Seki, R., Isobe, N., Kawaguchi, R., Oshima, S., Taniguchi, K., Nakagawa, K. Keiichi, Sekine, T., Yamazaki, M., Komuro, I., Kim, K. M. Kyeong Min, Teramoto, N., Jino, H., Ohta, Y., Watabe, H., Hayashi, T., Iida, H., Nishimura, T. Tohru, Nagae, A., Morishima, K., Shigeyama, T., Shimoyama, K., Yoshino, H., Kawai, Y. Yuko, Jeong, S. Y., Lee, J. Jae-Tae, Seo, J. H., Bae, J. H., Ahn, B. C., Chae, S. C., Lee, K. B., Cho, I. Ihnho, Chun, K., Won, K., Lee, H., Hong, G., Park, J., Shin, D., Kim, Y., Shim, B., Pavlovic, J. Maksimovic, Peovska, I. Irena, Vavlukis, M., Gorceva, D. Pop, Majstorov, V., Alexanderson, E. Erick, Meave, A., Ricalde, A., Teresinska, A. Anna, Sliwinski, M., Konieczna, S., Szymanska, M., Hendzel, P., Juraszynski, Z., Debski, A., Szumilak, B., Kostkiewicz, M. Magdalena, Wilkolek, P., Pasowicz, M., Klimeczek, P., Pieniazek, P., Przewlocki, T., Pieculewicz, M., Tracz, W., Szot, W., Trebacz, J., Zmudka, K., Podolec, P., Dziuk, M. Miroslaw, Kazmierczak, A., Kot, E., Pietrzykowski, J., Cholewa, M., Coutinho, M. C. Maria Azevedo, Correia, M. J., Cantinho, G., Conceição, I., Bernardes, A., Silva, A., Gaspar, F., Cunha, J. A. Correia da, Lourenço, C. Cândida, Roque, C., Ferrer-Antunes, A., Ferreira, M., Providência, L. A., Lima, J., Abreu, A. Ana, Castillejos, L., Henriksson, I., Oliveira, L., Rosário, L., Geão, A., Pereira, E., Colarinha, P., Romero-Farina, G., Candell-Riera, J., Aguadé-Bruix, S. Santiago, Leon, G. De, Caresia, A. P., Mila-Lopez, M., Garcia-Alonso, C., Pifarre-Montaner, P., Negre-Buso, M., Castell-Conesa, J., Mestre-Fusco, A., Porta-Biosca, F., Aguadé-Bruix, S. Santiago, Muxi, A. Africa, Paredes, P., Ortin, J., Duch, J., Diaz-Infante, E., Fuertes, S., Orus, J., Mont, L. L., Pons, F., Pollack, C., Hellermann, J. P., Namdar, M., Siegrist, P. T. Patrick, Koepfli, P., Bartenstein, N., Schurr, U., Jenni, R., Kaufmann, P. A., Hassad, R. Rim, Hamami, H., Sellem, A., Brahim, H. Ben, Caglar, M. Meltem, Mahmoudian, B., Aytemir, K., Kahraman, S., Arýcý, M., Kabakcý, G., Karabulut, E., Akincioglu, C. Cigdem, Berman, D. S., Nishina, H., Hayes, S. W., Kavanagh, P. B., Friedman, J. D., Slomka, P. J., Germano, G., Entok, E. Emre, Cavusoglu, Y., Vardareli, E., Timuralp, B., Cheetham, A., Naylor, V., Ghiotto, F., McGhie, J., Al-Housni, M. B., Kelion, A. D. Andrew, Hutchings, F., Hinton-Taylor, S., Birkbeck, P., Thatikonda, S., Feldkamp, M., Rosamond, T. Thomas, Raza, M., Panjrath, G. S. Gurusher, Haider, A., Jain, D., Yang, A., Schumacher, R., Reynolds, J., Clark, E., Speiser, D., Schindel, M., Hackney, T., Vacek, J., Jindal, V. Vikas, Dim, U. Uzodinma, Hamburg, L. M., Mouradian, V., Nichols, K. J., Akinboboye, O. O., Snyder, K., Polepalle, D., DePuey, G. Gordon, Khattak, H., Friedman, M., Thompson, L., Thompson, R. C. Randall, McGhie, A. I., Moser, K., O’Keefe, J. H., Fritsch, N., Bateman, T. M., Mut, F., Vidal, I., Rener, A., Nuñez, M., Alvarez, B., and Beretta, M. Mario
- Published
- 2005
- Full Text
- View/download PDF
12. Poster display II clinical general
- Author
-
Gurgenyan, S., Vatinyan, S., Nikogosyan, K., Edilyan, L., Chobanyan, B., Lacourcière, Y., Marcel Dumont, M., Lefebvre, J., Poirier, L., Côté, C., Peix, A., Alonso, O., Chae, I., Chung, J., Gutierrez, C., Kropp, J., Onsel, C., Silvasi, I., Llerena, L., Padhy, A., Garcia-Barreto, D., Trapaga, A., Asen, L., Infante, O., Ponce, F., Cabrera, L., Valiente, J., Tornes, F., Guerrero, I., Zayas, R., ones, M., Castro, J., Fayad, Y., Carrillo, R., Paz, A., Mehlsen, J., Hædersdal, C., Daou, D., Benada, A., Lebtahi, R., Idy-Peretti, I., Guludec, D., Coaguila, C., Vilain, D., Leenhardt, A., Heinicke, N., Benesch, B., Kaiser, T., Seegmüller, M., Schönberger, J., Eilles, C., Riegger, G., Holmer, S., Luchner, A., Kouris, N., Kontogianni, D., Goranitou, G., Sifaki, M., Kalkandi, E., Grassos, H., Papoulia, E., Babalis, D., Moralidis, E., Spyridonidis, T., Arsos, G., Karakatsanis, K., Karatzas, N., Parameswaran, R., Sundaram, P., Padma, S., Haridas, K., Zachariah, M., Kumar, S., Feola, M., Leonardi, G., Peano, S., Bianchi, A., Dutto, P., Guala, E., Biggi, A., Uslenghi, E., Filardi, P., Pace, L., Dellegrottaglie, S., Corrado, L., Cafiero, M., Camerino, R., Maglione, A., Polimeno, M., Zarrilli, A., Chiariello, M., Giorgetti, A., Gimelli, A., Marini, C., Schluter, M., Kusch, A., D'Aragona, I., Marzullo, P., Stanislao, M., Zanco, P., Inglese, E., Bertelli, P., Valle, G., Tassone, F., Pepino, R., Francini, A., Garrone, O., Occelli, M., Merlano, M., Florimonte, L., Pagani, L., Piatti, L., Butti, I., Maffioli, L., Casorelli, E., Dottore, F., Gentili, G., Agostini, M., Pieri, P., Milan, E., Giubbini, R., Mazzanti, M., Serenelli, M., Perna, G., Ferro, A., Duilio, C., Santomauro, M., Salvatore, M., Cuocolo, A., Bertagna, F., Bosio, G., Terzi, A., Paghera, B., Kaneta, T., Otani, H., Hakamatsuka, T., Fukuda, H., Nakazato, R., Moroi, M., Kunimasa, T., Furuhashi, T., Sugi, K., Yasuhi, W., Akihiro, S., Yukawa, A., Ryu, K., Kimio, T., Yasuhiko, T., Nariaki, E., Yasunori, W., Akashi, Y., Musha, H., Kida, K., Itoh, K., Inoue, K., Kawasaki, K., Hashimoto, N., Nakazawa, K., Miyake, F., Fukuzawa, S., Ozawa, S., Inagaki, M., Sugioka, J., Okino, S., Matsuo, S., Matsumoto, T., Nakae, I., Masuda, D., Horie, M., Mori, Y., Takahashi, K., Masai, M., Kawasaki, D., Kanemori, T., Okuda, S., Tanabe, K., Ohyanagi, M., OKuda, S., Toyama, T., Hoshizaki, H., Seki, R., Isobe, N., Kawaguchi, R., Oshima, S., Taniguchi, K., Nakagawa, K., Sekine, T., Yamazaki, M., Komuro, I., Kim, K., Teramoto, N., Jino, H., Ohta, Y., Watabe, H., Hayashi, T., Iida, H., Nishimura, T., Nagae, A., Morishima, K., Shigeyama, T., Shimoyama, K., Yoshino, H., Kawai, Y., Jeong, S., Lee, J., Seo, J., Bae, J., Ahn, B., Chae, S., Lee, K., Cho, I., Chun, K., Won, K., Lee, H., Hong, G., Park, J., Shin, D., Kim, Y., Shim, B., Pavlovic, J., Peovska, I., Vavlukis, M., Gorceva, D., Majstorov, V., Alexanderson, E., Meave, A., Ricalde, A., Teresinska, A., Sliwinski, M., Konieczna, S., Szymanska, M., Hendzel, P., Juraszynski, Z., Debski, A., Szumilak, B., Kostkiewicz, M., Wilkolek, P., Pasowicz, M., Klimeczek, P., Pieniazek, P., Przewlocki, T., Pieculewicz, M., Tracz, W., Szot, W., Trebacz, J., Zmudka, K., Podolec, P., Dziuk, M., Kazmierczak, A., Kot, E., Pietrzykowski, J., Cholewa, M., Coutinho, M., Correia, M., Cantinho, G., Conceição, I., Bernardes, A., Silva, A., Gaspar, F., Cunha, J., Lourenço, C., Roque, C., Ferrer-Antunes, A., Ferreira, M., Providência, L., Lima, J., Abreu, A., Castillejos, L., Henriksson, I., Oliveira, L., Rosário, L., Geão, A., Pereira, E., Colarinha, P., Romero-Farina, G., Candell-Riera, J., Aguadé-Bruix, S., Leon, G., Caresia, A., Mila-Lopez, M., Garcia-Alonso, C., Pifarre-Montaner, P., Negre-Buso, M., Castell-Conesa, J., Mestre-Fusco, A., Porta-Biosca, F., Muxi, A., Paredes, P., Ortin, J., Duch, J., Diaz-Infante, E., Fuertes, S., Orus, J., Mont, L., Pons, F., Pollack, C., Hellermann, J., Namdar, M., Siegrist, P., Koepfli, P., Bartenstein, N., Schurr, U., Jenni, R., Kaufmann, P., Hassad, R., Hamami, H., Sellem, A., Brahim, H., Caglar, M., Mahmoudian, B., Aytemir, K., Kahraman, S., Arýcý, M., Kabakcý, G., Karabulut, E., Akincioglu, C., Berman, D., Nishina, H., Hayes, S., Kavanagh, P., Friedman, J., Slomka, P., Germano, G., Entok, E., Cavusoglu, Y., Vardareli, E., Timuralp, B., Cheetham, A., Naylor, V., Ghiotto, F., McGhie, J., Al-Housni, M., Kelion, A., Hutchings, F., Hinton-Taylor, S., Birkbeck, P., Thatikonda, S., Feldkamp, M., Rosamond, T., Raza, M., Panjrath, G., Haider, A., Jain, D., Yang, A., Schumacher, R., Reynolds, J., Clark, E., Speiser, D., Schindel, M., Hackney, T., Vacek, J., Jindal, V., Dim, U., Hamburg, L., Mouradian, V., Nichols, K., Akinboboye, O., Snyder, K., Polepalle, D., DePuey, G., Khattak, H., Friedman, M., Thompson, L., Thompson, R., McGhie, A., Moser, K., O'Keefe, J., Fritsch, N., Bateman, T., Mut, F., Vidal, I., Rener, A., Nuñez, M., Alvarez, B., and Beretta, M.
- Published
- 2018
13. Efficient economic energy scheduling in smart cities using distributed energy resources
- Author
-
Manzoor Awais, Akram Waseem, Judge Malik Ali, Khan Naveed, and Khattak Hasan Ali
- Subjects
micro grid ,demand response ,multiobjective optimization ,home energy management ,distributed energy resources ,non-dominated sorting genetic algorithm ,Technology ,Science - Abstract
Machine learning provides a powerful mechanism to enhance the capabilities of the next generation of smart cities. Whether healthcare monitoring, building automation, energy management, or traffic management, use cases of capability enhancement using machine learning have been significant in recent years. This paper proposes a modeling approach for scheduling energy consumption within smart homes based on a non-dominated sorting genetic algorithm (NSGA). Distributed energy management plays a significant role in reducing energy consumption and carbon emissions as compared to centralized energy generation. Multiple energy consumers can schedule energy-consuming household tasks using home energy management systems in coordination to reduce economic costs and greenhouse gas emissions. In this work, such a home energy management system is used to collect energy price data from the electricity company via an embedded device-enabled smart meter and schedule energy consumption tasks based on this data. We schedule daily power consumption tasks using a multiobjective optimization method that considers environmental and economic sustainability. Two conflicting objectives are minimizing daily energy costs and reducing carbon dioxide emissions. Based on electricity tariffs, CO2 intensity, and the window of time during which electricity is consumed, energy consumption tasks involving distributed energy resources (DERs) and electricity consumption are scheduled. The proposed model is implemented in a model smart building consisting of 30 homes under 3 pricing schemes. The energy demand is spread out across a 24-hour period for points A2–A4 under CPP-PDC, which produces a more flattened curve than point A1. There are competing goals between electricity costs and carbon footprints at points B2–B4 under the CPP-PDC, where electricity demand is set between 20:00 and 0:00. Power grids’ peak energy demand is comparatively low when scheduling under CPP-PDC for points A5 and B5. Reducing carbon emissions, CPP-PDC reduces the maximum demand for electricity from the grid and the overall demand above the predetermined level. The maximum power demand from the grid is minimized for points A5 and B5, reducing up to 22% compared to A2. The proposed method minimizes both energy costs as well as CO2 emissions. A Pareto curve illustrates the trade-off between cost and CO2 emissions.
- Published
- 2024
- Full Text
- View/download PDF
14. A comparative study assessing the quality of life and bowel function in patients following laparoscopic and open anterior resection for rectal cancer
- Author
-
Khattak, H., primary, Siddiqi, N., additional, Parvaiz, A., additional, George, S., additional, and Flashman, K., additional
- Published
- 2014
- Full Text
- View/download PDF
15. Preventing black and gray hole attacks in AODV using optimal path routing and hash
- Author
-
Khattak, H., primary, Nizamuddin, N., additional, Khurshid, F., additional, and ul Amin, Noor, additional
- Published
- 2013
- Full Text
- View/download PDF
16. Post-exercise and adenosine blood clearance and myocardial count density characteristics of Tc-99m sestamibi and Tc-99m tetrofosmin
- Author
-
DEPUEY, G, primary, KHATTAK, H, additional, FRIEDMAN, M, additional, and THOMPSON, L, additional
- Published
- 2005
- Full Text
- View/download PDF
17. 98 Reproductive and endocrine outcomes after fresh and frozen ovarian transplantation: A systematic review and individual patient data meta-analysis.
- Author
-
Khattak, H., Malhas, R., Craciunas, L., Gallos, I., and Coomarasamy, A.
- Subjects
- *
OVARIAN transplantation , *REPRODUCTIVE health , *FREEZING - Published
- 2022
- Full Text
- View/download PDF
18. Efficacy and Causes of Failure of Endoscopic Subureteric Injection of Teflon in the Treatment of Primary Vesicoureteric Reflux
- Author
-
BHATTI, H. A., primary, KHATTAK, H., additional, and BOSTON, V. E., additional
- Published
- 1993
- Full Text
- View/download PDF
19. Poster display II clinical general
- Author
-
Gurgenyan, S., Vatinyan, S., Nikogosyan, K., Edilyan, L., Chobanyan, B., Lacourcière, Y., Marcel Dumont, M., Lefebvre, J., Poirier, L., Côté, C., Peix, A., Alonso, O., Chae, I., Chung, J., Gutierrez, C., Kropp, J., Onsel, C., Silvasi, I., Llerena, L., Padhy, A., Garcia-Barreto, D., Trapaga, A., Asen, L., Infante, O., Ponce, F., Cabrera, L., Valiente, J., Tornes, F., Guerrero, I., Zayas, R., ones, M., Castro, J., Fayad, Y., Carrillo, R., Paz, A., Mehlsen, J., Hædersdal, C., Daou, D., Benada, A., Lebtahi, R., Idy-Peretti, I., Guludec, D., Coaguila, C., Vilain, D., Leenhardt, A., Heinicke, N., Benesch, B., Kaiser, T., Seegmüller, M., Schönberger, J., Eilles, C., Riegger, G., Holmer, S., Luchner, A., Kouris, N., Kontogianni, D., Goranitou, G., Sifaki, M., Kalkandi, E., Grassos, H., Papoulia, E., Babalis, D., Moralidis, E., Spyridonidis, T., Arsos, G., Karakatsanis, K., Karatzas, N., Parameswaran, R., Sundaram, P., Padma, S., Haridas, K., Zachariah, M., Kumar, S., Feola, M., Leonardi, G., Peano, S., Bianchi, A., Dutto, P., Guala, E., Biggi, A., Uslenghi, E., Filardi, P., Pace, L., Dellegrottaglie, S., Corrado, L., Cafiero, M., Camerino, R., Maglione, A., Polimeno, M., Zarrilli, A., Chiariello, M., Giorgetti, A., Gimelli, A., Marini, C., Schluter, M., Kusch, A., D'Aragona, I., Marzullo, P., Stanislao, M., Zanco, P., Inglese, E., Bertelli, P., Valle, G., Tassone, F., Pepino, R., Francini, A., Garrone, O., Occelli, M., Merlano, M., Florimonte, L., Pagani, L., Piatti, L., Butti, I., Maffioli, L., Casorelli, E., Dottore, F., Gentili, G., Agostini, M., Pieri, P., Milan, E., Giubbini, R., Mazzanti, M., Serenelli, M., Perna, G., Ferro, A., Duilio, C., Santomauro, M., Salvatore, M., Cuocolo, A., Bertagna, F., Bosio, G., Terzi, A., Paghera, B., Kaneta, T., Otani, H., Hakamatsuka, T., Fukuda, H., Nakazato, R., Moroi, M., Kunimasa, T., Furuhashi, T., Sugi, K., Yasuhi, W., Akihiro, S., Yukawa, A., Ryu, K., Kimio, T., Yasuhiko, T., Nariaki, E., Yasunori, W., Akashi, Y., Musha, H., Kida, K., Itoh, K., Inoue, K., Kawasaki, K., Hashimoto, N., Nakazawa, K., Miyake, F., Fukuzawa, S., Ozawa, S., Inagaki, M., Sugioka, J., Okino, S., Matsuo, S., Matsumoto, T., Nakae, I., Masuda, D., Horie, M., Mori, Y., Takahashi, K., Masai, M., Kawasaki, D., Kanemori, T., Okuda, S., Tanabe, K., Ohyanagi, M., OKuda, S., Toyama, T., Hoshizaki, H., Seki, R., Isobe, N., Kawaguchi, R., Oshima, S., Taniguchi, K., Nakagawa, K., Sekine, T., Yamazaki, M., Komuro, I., Kim, K., Teramoto, N., Jino, H., Ohta, Y., Watabe, H., Hayashi, T., Iida, H., Nishimura, T., Nagae, A., Morishima, K., Shigeyama, T., Shimoyama, K., Yoshino, H., Kawai, Y., Jeong, S., Lee, J., Seo, J., Bae, J., Ahn, B., Chae, S., Lee, K., Cho, I., Chun, K., Won, K., Lee, H., Hong, G., Park, J., Shin, D., Kim, Y., Shim, B., Pavlovic, J., Peovska, I., Vavlukis, M., Gorceva, D., Majstorov, V., Alexanderson, E., Meave, A., Ricalde, A., Teresinska, A., Sliwinski, M., Konieczna, S., Szymanska, M., Hendzel, P., Juraszynski, Z., Debski, A., Szumilak, B., Kostkiewicz, M., Wilkolek, P., Pasowicz, M., Klimeczek, P., Pieniazek, P., Przewlocki, T., Pieculewicz, M., Tracz, W., Szot, W., Trebacz, J., Zmudka, K., Podolec, P., Dziuk, M., Kazmierczak, A., Kot, E., Pietrzykowski, J., Cholewa, M., Coutinho, M., Correia, M., Cantinho, G., Conceição, I., Bernardes, A., Silva, A., Gaspar, F., Cunha, J., Lourenço, C., Roque, C., Ferrer-Antunes, A., Ferreira, M., Providência, L., Lima, J., Abreu, A., Castillejos, L., Henriksson, I., Oliveira, L., Rosário, L., Geão, A., Pereira, E., Colarinha, P., Romero-Farina, G., Candell-Riera, J., Aguadé-Bruix, S., Leon, G., Caresia, A., Mila-Lopez, M., Garcia-Alonso, C., Pifarre-Montaner, P., Negre-Buso, M., Castell-Conesa, J., Mestre-Fusco, A., Porta-Biosca, F., Muxi, A., Paredes, P., Ortin, J., Duch, J., Diaz-Infante, E., Fuertes, S., Orus, J., Mont, L., Pons, F., Pollack, C., Hellermann, J., Namdar, M., Siegrist, P., Koepfli, P., Bartenstein, N., Schurr, U., Jenni, R., Kaufmann, P., Hassad, R., Hamami, H., Sellem, A., Brahim, H., Caglar, M., Mahmoudian, B., Aytemir, K., Kahraman, S., Arýcý, M., Kabakcý, G., Karabulut, E., Akincioglu, C., Berman, D., Nishina, H., Hayes, S., Kavanagh, P., Friedman, J., Slomka, P., Germano, G., Entok, E., Cavusoglu, Y., Vardareli, E., Timuralp, B., Cheetham, A., Naylor, V., Ghiotto, F., McGhie, J., Al-Housni, M., Kelion, A., Hutchings, F., Hinton-Taylor, S., Birkbeck, P., Thatikonda, S., Feldkamp, M., Rosamond, T., Raza, M., Panjrath, G., Haider, A., Jain, D., Yang, A., Schumacher, R., Reynolds, J., Clark, E., Speiser, D., Schindel, M., Hackney, T., Vacek, J., Jindal, V., Dim, U., Hamburg, L., Mouradian, V., Nichols, K., Akinboboye, O., Snyder, K., Polepalle, D., DePuey, G., Khattak, H., Friedman, M., Thompson, L., Thompson, R., McGhie, A., Moser, K., O'Keefe, J., Fritsch, N., Bateman, T., Mut, F., Vidal, I., Rener, A., Nuñez, M., Alvarez, B., Beretta, M., Gurgenyan, S., Vatinyan, S., Nikogosyan, K., Edilyan, L., Chobanyan, B., Lacourcière, Y., Marcel Dumont, M., Lefebvre, J., Poirier, L., Côté, C., Peix, A., Alonso, O., Chae, I., Chung, J., Gutierrez, C., Kropp, J., Onsel, C., Silvasi, I., Llerena, L., Padhy, A., Garcia-Barreto, D., Trapaga, A., Asen, L., Infante, O., Ponce, F., Cabrera, L., Valiente, J., Tornes, F., Guerrero, I., Zayas, R., ones, M., Castro, J., Fayad, Y., Carrillo, R., Paz, A., Mehlsen, J., Hædersdal, C., Daou, D., Benada, A., Lebtahi, R., Idy-Peretti, I., Guludec, D., Coaguila, C., Vilain, D., Leenhardt, A., Heinicke, N., Benesch, B., Kaiser, T., Seegmüller, M., Schönberger, J., Eilles, C., Riegger, G., Holmer, S., Luchner, A., Kouris, N., Kontogianni, D., Goranitou, G., Sifaki, M., Kalkandi, E., Grassos, H., Papoulia, E., Babalis, D., Moralidis, E., Spyridonidis, T., Arsos, G., Karakatsanis, K., Karatzas, N., Parameswaran, R., Sundaram, P., Padma, S., Haridas, K., Zachariah, M., Kumar, S., Feola, M., Leonardi, G., Peano, S., Bianchi, A., Dutto, P., Guala, E., Biggi, A., Uslenghi, E., Filardi, P., Pace, L., Dellegrottaglie, S., Corrado, L., Cafiero, M., Camerino, R., Maglione, A., Polimeno, M., Zarrilli, A., Chiariello, M., Giorgetti, A., Gimelli, A., Marini, C., Schluter, M., Kusch, A., D'Aragona, I., Marzullo, P., Stanislao, M., Zanco, P., Inglese, E., Bertelli, P., Valle, G., Tassone, F., Pepino, R., Francini, A., Garrone, O., Occelli, M., Merlano, M., Florimonte, L., Pagani, L., Piatti, L., Butti, I., Maffioli, L., Casorelli, E., Dottore, F., Gentili, G., Agostini, M., Pieri, P., Milan, E., Giubbini, R., Mazzanti, M., Serenelli, M., Perna, G., Ferro, A., Duilio, C., Santomauro, M., Salvatore, M., Cuocolo, A., Bertagna, F., Bosio, G., Terzi, A., Paghera, B., Kaneta, T., Otani, H., Hakamatsuka, T., Fukuda, H., Nakazato, R., Moroi, M., Kunimasa, T., Furuhashi, T., Sugi, K., Yasuhi, W., Akihiro, S., Yukawa, A., Ryu, K., Kimio, T., Yasuhiko, T., Nariaki, E., Yasunori, W., Akashi, Y., Musha, H., Kida, K., Itoh, K., Inoue, K., Kawasaki, K., Hashimoto, N., Nakazawa, K., Miyake, F., Fukuzawa, S., Ozawa, S., Inagaki, M., Sugioka, J., Okino, S., Matsuo, S., Matsumoto, T., Nakae, I., Masuda, D., Horie, M., Mori, Y., Takahashi, K., Masai, M., Kawasaki, D., Kanemori, T., Okuda, S., Tanabe, K., Ohyanagi, M., OKuda, S., Toyama, T., Hoshizaki, H., Seki, R., Isobe, N., Kawaguchi, R., Oshima, S., Taniguchi, K., Nakagawa, K., Sekine, T., Yamazaki, M., Komuro, I., Kim, K., Teramoto, N., Jino, H., Ohta, Y., Watabe, H., Hayashi, T., Iida, H., Nishimura, T., Nagae, A., Morishima, K., Shigeyama, T., Shimoyama, K., Yoshino, H., Kawai, Y., Jeong, S., Lee, J., Seo, J., Bae, J., Ahn, B., Chae, S., Lee, K., Cho, I., Chun, K., Won, K., Lee, H., Hong, G., Park, J., Shin, D., Kim, Y., Shim, B., Pavlovic, J., Peovska, I., Vavlukis, M., Gorceva, D., Majstorov, V., Alexanderson, E., Meave, A., Ricalde, A., Teresinska, A., Sliwinski, M., Konieczna, S., Szymanska, M., Hendzel, P., Juraszynski, Z., Debski, A., Szumilak, B., Kostkiewicz, M., Wilkolek, P., Pasowicz, M., Klimeczek, P., Pieniazek, P., Przewlocki, T., Pieculewicz, M., Tracz, W., Szot, W., Trebacz, J., Zmudka, K., Podolec, P., Dziuk, M., Kazmierczak, A., Kot, E., Pietrzykowski, J., Cholewa, M., Coutinho, M., Correia, M., Cantinho, G., Conceição, I., Bernardes, A., Silva, A., Gaspar, F., Cunha, J., Lourenço, C., Roque, C., Ferrer-Antunes, A., Ferreira, M., Providência, L., Lima, J., Abreu, A., Castillejos, L., Henriksson, I., Oliveira, L., Rosário, L., Geão, A., Pereira, E., Colarinha, P., Romero-Farina, G., Candell-Riera, J., Aguadé-Bruix, S., Leon, G., Caresia, A., Mila-Lopez, M., Garcia-Alonso, C., Pifarre-Montaner, P., Negre-Buso, M., Castell-Conesa, J., Mestre-Fusco, A., Porta-Biosca, F., Muxi, A., Paredes, P., Ortin, J., Duch, J., Diaz-Infante, E., Fuertes, S., Orus, J., Mont, L., Pons, F., Pollack, C., Hellermann, J., Namdar, M., Siegrist, P., Koepfli, P., Bartenstein, N., Schurr, U., Jenni, R., Kaufmann, P., Hassad, R., Hamami, H., Sellem, A., Brahim, H., Caglar, M., Mahmoudian, B., Aytemir, K., Kahraman, S., Arýcý, M., Kabakcý, G., Karabulut, E., Akincioglu, C., Berman, D., Nishina, H., Hayes, S., Kavanagh, P., Friedman, J., Slomka, P., Germano, G., Entok, E., Cavusoglu, Y., Vardareli, E., Timuralp, B., Cheetham, A., Naylor, V., Ghiotto, F., McGhie, J., Al-Housni, M., Kelion, A., Hutchings, F., Hinton-Taylor, S., Birkbeck, P., Thatikonda, S., Feldkamp, M., Rosamond, T., Raza, M., Panjrath, G., Haider, A., Jain, D., Yang, A., Schumacher, R., Reynolds, J., Clark, E., Speiser, D., Schindel, M., Hackney, T., Vacek, J., Jindal, V., Dim, U., Hamburg, L., Mouradian, V., Nichols, K., Akinboboye, O., Snyder, K., Polepalle, D., DePuey, G., Khattak, H., Friedman, M., Thompson, L., Thompson, R., McGhie, A., Moser, K., O'Keefe, J., Fritsch, N., Bateman, T., Mut, F., Vidal, I., Rener, A., Nuñez, M., Alvarez, B., and Beretta, M.
20. Variations in sexual and reproductive health services for the provision of comprehensive contraceptive and abortion services across Europe: A questionnaire-based study commissioned by the European Board and College of Obstetrics & Gynaecology (EBCOG) and European Society of Contraception (ESC).
- Author
-
Khattak H, Tsiapakidou S, Mukhopadhyay S, Mahmood T, Cameron S, Kubba A, Merki-Feld G, Savona-Ventura C, Klanjscek J, and Bitzer J
- Subjects
- Humans, Europe, Female, Surveys and Questionnaires, Pregnancy, Health Services Accessibility statistics & numerical data, Family Planning Services statistics & numerical data, Abortion, Induced statistics & numerical data, Reproductive Health Services standards, Contraception methods, Contraception statistics & numerical data
- Abstract
A questionnaire-based study was jointly organised by European Board and College of Obstetrics and Gynaecology and European Society of Contraception to evaluate the current status as regards access and quality of care regarding contraception, abortion care, and pre-conceptional counselling and care among the 26 European countries. There are considerable variations among these countries as regards the provision of contraceptive services and abortion care. There is ample room for improvement through European training and education programs. However, the most important difference is the absence of a comprehensive network of healthcare providers in various countries to deliver these services at different points of access. There is notable absence of educational programs and instructional materials tailored specifically for nurses and midwives in several countries. This deficiency impedes the professional development and skills enhancement of these healthcare professionals, potentially compromising the quality of healthcare services provided to women in these countries., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
21. Use of anticoagulants to improve pregnancy outcomes in couples positive for M2 haplotype: A systematic review.
- Author
-
Khattak H, Aleem Husain S, Baker D, and Greer I
- Subjects
- Female, Humans, Pregnancy, Anticoagulants, Cohort Studies, Haplotypes, Placenta, Randomized Controlled Trials as Topic, Pregnancy Outcome, Premature Birth
- Abstract
Background: Placental mediated pregnancy complications (PMPC) are common, often recurring, and pose a significant health risk to mother and fetus. Evidence suggests that the hypercoagulable state associated with many PMPC, could reflect reduced expression of Annexin 5 (ANXA5), a naturally occurring anticoagulant protein in placental tissue. The ANXA5 M2 haplotype is a genetic variant, which results in reduced expression of ANXA5 protein. M2 haplotype carrier couples may therefore be at increased risk of PMPC. Evidence regarding the effectiveness of anticoagulation to prevent PMPC is inconsistent. Furthermore, studies have not selected or stratified for M2 haplotype carriers, in whom there is a predisposition to hypercoagulability, to assess the effectiveness of anticoagulation, which may vary from those without the M2 haplotype., Objectives and Rationale: The aim of this study was to systematically review the current evidence to assess whether anticoagulant treatment improves pregnancy outcomes in couples positive for M2 haplotype., Search Methods: The review was registered on PROSPERO (CRD42022343943). A comprehensive literature search was performed using MEDLINE, Embase and Cochrane collaboration databases from inception to January 2023. Two reviewers assessed the articles for eligibility and extracted the data simultaneously. Primary outcome was successful pregnancy and live birth. Secondary outcomes included PMPC (implantation failure, miscarriage, pre-eclampsia, preterm birth and fetal growth restriction)., Outcomes: From a pool of 410 references, 10 were selected for full text review, of which three studies (a post hoc analysis of a randomised controlled trial, cohort study and a case report) were included in this review. Included studies comprised of 223 individuals, 129 of whom who received anticoagulation treatment after testing positive for M2 haplotype. The studies collectively showed an improvement in pregnancy outcomes in M2 haplotype positive individuals however, given the heterogeneity of studies, it was not possible to conduct a meta-analysis and draw firm conclusions., Wider Implications: Current evidence is limited, such that the value of screening couples for the M2 haplotype to select or stratify for treatment with prophylactic anticoagulation remains unknown. Thus, further studies including well designed, large, multi-centre randomised controlled trials are required to assess whether anticoagulation treatment will be effective in improving pregnancy outcomes in M2 haplotype couples., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
22. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
- Author
-
Henderson I, Black N, Khattak H, Gupta JK, and Rimmer MP
- Subjects
- Humans, Female, Retrospective Studies, Data Collection, Documentation, Endometrial Hyperplasia diagnosis, Endometrial Hyperplasia epidemiology, Endometrial Hyperplasia therapy, Endometrial Neoplasms
- Abstract
Background: Endometrial hyperplasia (EH) is a precusor lesion for endometrial cancer (EC), the commonest gynaecological malignancy in high-income countries. EH is a proliferation of glandular tissue, classified as either non-atypical endometrial hyperplasia (NEH) or, if the cytological features are abnormal, atypical endometrial hyperplasia (AEH). The clinical significance of AEH is that patients face both a high risk of having occult EC and a high risk of progression to EC if untreated. Recommendations on the care of women with EH were introduced by United Kingdom-wide guidance (Green-top Guide No. 67, 2016). National adherence to guidance is unknown. We aimed to describe the care of patients with EH; to compare the patterns of care for those with EH with national guidance to identify opportunities for quality improvement; and to compare patterns of care prior to and following the introduction of national guidance to understand its impact., Methods and Findings: In this UK-wide patient-level clinical audit, we included 3,307 women who received a new histological diagnosis of EH through a gynaecology service between 1 January 2012 and 30 June 2020. We described first-line management, management at 2 years, and surgical characteristics prior to and following national guidance for EH using proportions and 95% confidence intervals (CIs) and compared process measures between time periods using multilevel Poisson regression. Of the 3,307 patients, 1,570 had NEH and 1,511 had AEH between 2012 and 2019. An additional 85 patients had NEH and 141 had AEH during 2020. Prior to national guidance, 9% (95% CI [6%, 15%]) received no initial treatment for NEH compared with 3% (95% CI [1%, 5%]) post-guidance; 31% (95% CI [26%, 36%]) and 48% (95% CI [43% 53%]) received an intrauterine progestogen, respectively, in the same periods. The predominant management of women with AEH did not differ, with 68% (95% CI [61%, 74%]) and 67% (95 CI [63%, 71%]) receiving first-line hysterectomy, respectively. By 2 years, follow-up to histological regression without hysterectomy increased from 38% (95% CI [33%, 43%]) to 52% (95% CI [47%, 58%]) for those with NEH (rate ratio (RR) 1.38, 95% CI [1.18, 1.63] p < 0.001). We observed an increase in the use of total laparoscopic hysterectomy among those with AEH (RR 1.26, 95% CI [1.04, 1.52]). In the later period, 37% (95% CI [29%, 44%]) of women initially diagnosed with AEH who underwent a first-line hysterectomy, received an upgraded diagnosis of EC. Study limitations included retrospective data collection from routine clinical documentation and the inability to comprehensively understand the shared decision-making process where care differed from guidance., Conclusions: The care of patients with EH has changed in accordance with national guidance. More women received first-line medical management of NEH and were followed up to histological regression. The follow-up of those with AEH who do not undergo hysterectomy must be improved, given their very high risk of coexistent cancer and high risk of developing cancer., Competing Interests: JG contributed to Green-top Guideline No.67 on behalf of the British Society for Gynaecological Endoscopy., (Copyright: © 2024 Henderson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2024
- Full Text
- View/download PDF
23. Drug repurposing of FDA-approved anti-viral drugs via computational screening against novel 6M03 SARS-COVID-19.
- Author
-
Waseem W, Zafar R, Jan MS, Alomar TS, Almasoud N, Rauf A, and Khattak H
- Subjects
- Humans, Antiviral Agents, SARS-CoV-2, Drug Repositioning methods, Pandemics, Molecular Docking Simulation, Peptide Hydrolases pharmacology, COVID-19
- Abstract
Objective: The COVID-19 pandemic has been recognized as severe acute respiratory syndrome, one of the worst and disastrous infectious diseases in human history. Until now, there is no cure to this contagious infection although some multinational pharmaceutical companies have synthesized the vaccines and injecting them into humans, but a drug treatment regimen is yet to come., Aim: Among the multiple areas of SARS-CoV-2 that can be targeted, protease protein has significant values due to its essential role in viral replication and life. The repurposing of FDA-approved drugs for the treatment of COVID-19 has been a critical strategy during the pandemic due to the urgency of effective therapies. The novelty in this work refers to the innovative use of existing drugs with greater safety, speed, cost-effectiveness, broad availability, and diversity in the mechanism of action that have been approved and developed for other medical conditions., Methods: In this research work, we have engaged drug reprofiling or drug repurposing to recognize possible inhibitors of protease protein 6M03 in an instantaneous approach through computational docking studies., Results: We screened 16 FDA-approved anti-viral drugs that were known for different viral infections to be tested against this contagious novel strain. Through these reprofiling studies, we come up with 5 drugs, namely, Delavirdine, Fosamprenavir, Imiquimod, Stavudine, and Zanamivir, showing excellent results with the negative binding energies in Kcal/mol as - 8.5, - 7.0, - 6.8, - 6.8, and - 6.6, respectively, in the best binding posture. In silico studies allowed us to demonstrate the potential role of these drugs against COVID-19., Conclusion: In our study, we also observed the nucleotide sequence of protease protein consisting of 316 amino acid residues and the influence of these pronouncing drugs over these sequences. The outcome of this research work provides researchers with a track record for carrying out further investigational procedures by applying docking simulations and in vitro and in vivo experimentation with these reprofile drugs so that a better drug can be formulated against coronavirus., (© 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.)
- Published
- 2024
- Full Text
- View/download PDF
24. FIGO best practice guidance in surgical consent.
- Author
-
Topcu EG, McClenahan P, Pule K, Khattak H, Karsli SE, Cukelj M, Ubom AE, Algurjia E, Ozpinar K, Perez YR, Bunu R, Sanabria LS, Portilla FJR, Pumpure E, Roy P, and Fogarty P
- Subjects
- Pregnancy, Female, Humans, Disclosure, Informed Consent, Physicians
- Abstract
Obtaining medical consent preoperatively is one of the key steps in preparing for surgery, and is an important step in informed decision making with the patient. According to good medical practice guidelines, doctors are required to have the knowledge and skills to treat patients as well as inform them, respect their wishes, and establish trust between themselves and their patients. Valid consent includes elements of competence, disclosure, understanding, and voluntariness. Documentation of these elements is also very important. The International Federation of Gynecology and Obstetrics (FIGO) Education Communication and Advocacy Consortium (ECAC) has realized that the quality of consent varies considerably across the world and has developed simple guidelines regarding consent and procedure-specific checklists for the most common obstetric and gynecological procedures., (© 2023 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.)
- Published
- 2023
- Full Text
- View/download PDF
25. Advancing postgraduate training in obstetrics and gynaecology: Report from ENTOG UK exchange and scientific meeting.
- Author
-
Khattak H, Rejayee M, Newnham-Hill A, and Odendaal J
- Subjects
- Female, Pregnancy, Humans, Education, Medical, Graduate, United Kingdom, Gynecology education, Obstetrics education
- Abstract
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2023
- Full Text
- View/download PDF
26. Chromosomal polymorphisms in assisted reproduction: a systematic review and meta-analysis.
- Author
-
Ralapanawe MSB, Khattak H, Hapangama HR, Weerakkody GR, Papadopoulou A, and Gallos I
- Abstract
This systematic review and meta-analysis investigated the effects of chromosomal polymorphisms in reproductive outcomes following IVF or ICSI. Literature in CENTRAL, CINAHL, EMBASE and MEDLINE were searched from 1974 to March 2020 with no language restrictions. Ten published cohort studies were chosen for analysis. Studies included females, males and couples undergoing assisted reproductive treatments with the presence or absence of chromosomal polymorphisms. Reproductive outcomes were reported and their quality assessed using the Newcastle-Ottawa Quality Assessment Scale. Meta-analysis of five cohort studies (9,659 participants) indicated that female carriers with chromosomal polymorphisms had a higher miscarriage rate compared to non-carriers (risk ratio (RR) 1.54 (95% CI 1.19-1.98), whereas no significant association was found for males (RR 0.96, 95% CI 0.64-1.43) and couples (RR 1.93, 95% CI 0.32-11.83) indicating that this effect appeared to be gender-dependent. There was no association between chromosomal polymorphisms and a higher rate of biochemical, clinical, ongoing pregnancy, and preterm and live birth.
- Published
- 2023
- Full Text
- View/download PDF
27. Postgraduate Training in Pediatric and Adolescent Gynecology: Trainees' Perspectives.
- Author
-
Topcu EG, Khattak H, Boekhorst F, Horala A, Henriques MG, and Roos EJ
- Subjects
- Female, Pregnancy, Adult, Humans, Adolescent, Child, Cross-Sectional Studies, Europe, Curriculum, Gynecology education, Obstetrics education, Internship and Residency
- Abstract
Objective: The purpose of this study was to evaluate resident trainees' perspectives on the pediatric and adolescent gynecology (PAG) training in obstetrics and gynecology training programs in Europe., Study Design: This study was a cross-sectional survey using an online questionnaire, on the basis of the PAG training in obstetrics and gynecology section of the European Board & College of Obstetrics and Gynaecology Project of Achieving Consensus in Training curriculum. We aimed to survey the national programs in 35 European Network of Trainees in Obstetrics and Gynaecology (ENTOG) member countries. Taking part in the survey was voluntary. The questionnaire was shared on the ENTOG online platforms., Results: Ninety obstetrics and gynecology trainees in 33 of 35 countries responded to our questionnaire. Of the 35 ENTOG member countries, 33 participated in the survey, and a total of 90 responses were collected, giving a response rate of 9% of all European trainees and representing 94% of the member countries. Only 27% of trainees reported having a PAG rotation during their training program, and a PAG elective was only available to 34% of the trainees. Forty-one percent reported that PAG training was not included in their curriculum (no official rotations or lectures planned). Despite the lack of formal training, 72% of trainees felt able to diagnose and manage prepubertal vaginal bleeding and adnexal masses in children and adolescents by the end of their training. Most (58%) also confirmed that they could determine indications for treatment of vulval, vaginal, perineal, and rectal conditions. However, despite scoring positively for the management and counseling of subjects that often overlap with adult patients, such as "contraception in adolescents with health problems," "acute abdominal pain," "menstrual abnormalities," and "vaginal discharge," the study revealed poorer scores when the trainees were asked about more specific PAG topics such as "premature puberty" and "developmental disorders of the genital tract.", Conclusion: Most core training programs across Europe do not include formal PAG training, and trainees reported a need to improve the provision of core PAG training in Europe., (Copyright © 2022. Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
28. Experiences of young girls and women undergoing ovarian tissue cryopreservation: a systematic review and thematic synthesis.
- Author
-
Khattak H, Woodman H, Afifi Y, Amorim CA, Fishel S, Gallos I, Coomarasamy A, and Topping A
- Subjects
- Humans, Female, Qualitative Research, Fertility, Cryopreservation methods, Fertility Preservation
- Abstract
The aim of this study was to explore the experiences of young girls and women who underwent or considered ovarian tissue cryopreservation (OTC) using a systematic review of qualitative studies with thematic synthesis framework. Major electronic databases: MEDLINE, EMBASE, the Cochrane Library, CINAHL and PsycINFO were searched from 1946 to May 2020 and reference lists of relevant articles were hand searched. Any studies that described a qualitative inquiry and highlighted the experiences of women with regards to OTC were included. Two independent reviewers screened the title and abstracts and made a selection against inclusion criteria. Main outcomes measures were experiences of women who have considered and/or undergone OTC, decision making in women who underwent or considered OTC and patient education. Nineteen studies were assessed for full text eligibility and four were included in analysis. 144 verbatim quotations from 85 participants in high income countries (UK, USA and Denmark) were included. Two studies adopted grounded theory approach, one phenomenology and one inductive content analysis. Four themes were generated; participants described their experiences as emotional, involving complex decision-making, helping them prepare for the long-term consequences of potentially losing their fertility and hormonal function, as well as their experience being educational. Additionally, the more practical aspects of the procedure such as OTC being invasive as well as costs implications were highlighted. Women and young girls are often involved in making time-sensitive decisions whether or not to undergo OTC. Healthcare professionals involved in the care of young girls and women undergoing this method need to also take into consideration the emotional wellbeing of the patients as well as the time and expertise it requires to help them make an informed decision.
- Published
- 2022
- Full Text
- View/download PDF
29. Folic acid fortification of flour to prevent neural tube defects in Europe - A position statement by the European Board and college of obstetrics and gynaecology (EBCOG).
- Author
-
Petch S, McAuliffe F, O'Reilly S, Murphy C, Coulter-Smith S, de Campos DA, Khattak H, and Mahmood T
- Subjects
- Pregnancy, Child, Female, Humans, Folic Acid therapeutic use, Flour, Food, Fortified, Gynecology, Neural Tube Defects prevention & control
- Abstract
Neural tube defects are disabling birth defects developing during the very early stages of conception. Children born with spina bifida face significant physical, psychological and social consequences. They may have bowel and urinary dysfunction, and no lower limb muscle control, resulting in lifelong wheelchair use. There is robust evidence that periconceptual folic acid supplementation prevents neural tube defects, when compared with no intervention. However, approximately 40% pregnancies in Europe are unplanned, and women may therefore not be taking prophylactic folic acid at the time of conception. There is evidence that low dose folic acid consumption via flour fortification provides further benefits in prevention of neural tube defects., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
30. EBCOG position statement inequalities in antenatal care provision in Europe: In the wake of an EBCOG survey.
- Author
-
Khattak H, Messinis IE, Mukhopadhyay S, and Mahmood T
- Subjects
- Female, Pregnancy, Humans, Prenatal Care, Europe, European Union, Socioeconomic Factors, Gynecology, Obstetrics
- Abstract
Health inequalities adversely affect the health outcomes generally but more so for those who are socially deprived, immigrants of unknown status and low socioeconomic status. The inequitable access to care during pregnancy can lead to long term adverse inter-generational effects. Current economic crisis within Europe will have deepening effect on the health of the vulnerable families. The European Board and College of Obstetrics and Gynaecology calls for action by the European Union., (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
31. The implementation of the European Working Time Directive in Europe and its impact on training in obstetrics and gynaecology: A ten year follow-up.
- Author
-
Goncalves-Henriques M, Horala A, Topcu EG, Boekhorst F, and Khattak H
- Subjects
- Female, Pregnancy, Humans, Cross-Sectional Studies, Follow-Up Studies, Europe, Gynecology education, Obstetrics education
- Abstract
Objective: To reassess the compliance with the European Working Time Directive (EWTD) in the member countries of the European Network of Trainees in Obstetrics and Gynaecology (ENTOG) and to investigate the impact of the EWTD on training., Study Design: In this observational, cross-sectional study, an online questionnaire, containing multiple-choice questions and open questions, was distributed among Obstetrics and Gynaecology trainees in 33 ENTOG member countries. The questionnaire was designed as a follow-up of a similar survey conducted by ENTOG in 2009 and assessed the overall compliance with the EWTD, the adaptations needed to achieve this compliance, the impact of the EWTD on the quality of training and the well-being of trainees. The answers were analysed using descriptive statistics in Microsoft Excel., Results: 59 responses from 28/33 (84.8%) ENTOG member countries were collected. Only 5 out of 28 (17.9%) countries were found to be nationally compliant with EWTD. There were no clear differences in the compliance between different types of the hospitals (university/teaching/district), but a trend was observed towards higher rate of implementation in smaller hospitals (<1500 deliveries per year). Regarding the changes needed to become EWTD-compliant and yet maintain high-quality training, the most common suggestions were: hiring extra junior doctors, restructuring training, having less doctors on duty simultaneously, consultants performing more hands on work, dedicated training sessions, reduction of administrative tasks and simulation training for surgical skills. The majority of trainees, 7 out of 12, (58.3%) in the EWTD-compliant hospitals experienced a positive effect on their training, whereas the majority of trainees in non-compliant hospitals, 31 out of 47, (66%) were uncertain about the impact of the EWTD on the quality of training. Among the positive changes, better work-life balance and more consultants available out of the daily working hours were listed., Conclusions: Despite the introduction and implementation of the EWTD over two decades ago, the compliance rates across Europe remain low and seem not to have altered in the last ten years. In order to ensure the quality of training and, most importantly patient safety, we suggest that European nations keep striving to implement the EWTD for doctors in training. We also suggest for nations that have yet to implement this directive to use the strategies as an exemplar in countries that follow EWTD., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
32. Care of pregnant women with epilepsy in the United Kingdom: A national survey of healthcare professionals.
- Author
-
Taylor E, Junaid F, Khattak H, Sheikh J, Ghosh J, Kemah BL, Nelson-Piercy C, Morley K, Moss N, Knox E, Allotey J, and Thangaratinam S
- Subjects
- Cross-Sectional Studies, Delivery of Health Care, Female, Humans, Pregnancy, Prospective Studies, United Kingdom, Epilepsy therapy, Pregnant Women
- Abstract
Objectives: To map the care provided to pregnant women with epilepsy in UK maternity units and identify future research priorities by conducting a nationwide survey of healthcare professionals., Study Design: A prospective cross-sectional electronic survey was conducted between 29 April and 30 October 2021. The survey included 23 questions developed and refined with relevant stakeholders, including a woman with lived experience of epilepsy and pregnancy. We used descriptive analyses to summarise responses and estimated proportions with medians and interquartile ranges., Results: 144 individual healthcare professionals from 94 hospitals, representing 77 NHS Trusts, participated in the survey. Obstetricians were the most common responders (45%, 65/144) and almost half (47%, 7/15) of regions had a survey response rate per NHS Trust greater than 50%. Six pregnant women with epilepsy, on average, were booked into antenatal care per hospital per month, and 49% (46/94) of hospitals saw women for specialist antenatal care in the first trimester. The care provided across healthcare systems varied, with multiple pathways for referral to specialist care within regions. Midwife referral was the most used care pathway (80%, 75/94). Less than a third of hospitals (31%, 29/94) ran joint obstetric/neurology clinics for pregnant women with epilepsy. Most survey respondents (81%, 117/144) were confident talking to pregnant women about their risk of seizures but only a minority (20%, 29/144) used validated calculators to assess this risk. There was broad agreement across healthcare professionals that the priorities for research should focus on how to improve communication and address pregnant women's concerns regarding epilepsy and pregnancy, and to develop further understanding on the optimal use and long-term effects of anti-seizure medication., Conclusion: Our UK nationwide survey of hospital-based maternity services for pregnant women with epilepsy identified wide variation in when, how and by whom these women are seen, with differences between and within the UK regions. This survey highlights areas for improvement in the care of pregnant women with epilepsy., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
33. NICE guideline review: neonatal infection: antibiotics for prevention and treatment (NG195).
- Author
-
Paul SP, Khattak H, Kini PK, Heaton PA, and Goel N
- Subjects
- Anti-Bacterial Agents therapeutic use, Humans, Infant, Newborn, Communicable Diseases, Neonatology
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2022
- Full Text
- View/download PDF
34. Smart Healthcare System for Severity Prediction and Critical Tasks Management of COVID-19 Patients in IoT-Fog Computing Environments.
- Author
-
Hameed Abdulkareem K, Awad Mutlag A, Musa Dinar A, Frnda J, Abed Mohammed M, Hasan Zayr F, Lakhan A, Kadry S, Ali Khattak H, and Nedoma J
- Subjects
- Algorithms, Delivery of Health Care, Humans, COVID-19, Internet of Things
- Abstract
COVID-19 has depleted healthcare systems around the world. Extreme conditions must be defined as soon as possible so that services and treatment can be deployed and intensified. Many biomarkers are being investigated in order to track the patient's condition. Unfortunately, this may interfere with the symptoms of other diseases, making it more difficult for a specialist to diagnose or predict the severity level of the case. This research develops a Smart Healthcare System for Severity Prediction and Critical Tasks Management (SHSSP-CTM) for COVID-19 patients. On the one hand, a machine learning (ML) model is projected to predict the severity of COVID-19 disease. On the other hand, a multi-agent system is proposed to prioritize patients according to the seriousness of the COVID-19 condition and then provide complete network management from the edge to the cloud. Clinical data, including Internet of Medical Things (IoMT) sensors and Electronic Health Record (EHR) data of 78 patients from one hospital in the Wasit Governorate, Iraq, were used in this study. Different data sources are fused to generate new feature pattern. Also, data mining techniques such as normalization and feature selection are applied. Two models, specifically logistic regression (LR) and random forest (RF), are used as baseline severity predictive models. A multi-agent algorithm (MAA), consisting of a personal agent (PA) and fog node agent (FNA), is used to control the prioritization process of COVID-19 patients. The highest prediction result is achieved based on data fusion and selected features, where all examined classifiers observe a significant increase in accuracy. Furthermore, compared with state-of-the-art methods, the RF model showed a high and balanced prediction performance with 86% accuracy, 85.7% F-score, 87.2% precision, and 86% recall. In addition, as compared to the cloud, the MAA showed very significant performance where the resource usage was 66% in the proposed model and 34% in the traditional cloud, the delay was 19% in the proposed model and 81% in the cloud, and the consumed energy was 31% in proposed model and 69% in the cloud. The findings of this study will allow for the early detection of three severity cases, lowering mortality rates., Competing Interests: The authors declared that they have no conflicts of interest., (Copyright © 2022 Karrar Hameed Abdulkareem et al.)
- Published
- 2022
- Full Text
- View/download PDF
35. What are my options? Fertility preservation methods for young girls and women.
- Author
-
Khattak H and Amorim CA
- Subjects
- Cryopreservation methods, Female, Fertility, Humans, Fertility Preservation methods, Neoplasms
- Published
- 2022
- Full Text
- View/download PDF
36. Correction to: Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.
- Author
-
Khattak H, Malhas R, Craciunas L, Afifi Y, Amorim CA, Fishel S, Silber S, Gook D, Demeestere I, Bystrova O, Lisyanskaya A, Manikhas G, Lotz L, Dittrich R, Colmorn LB, Macklon KT, Hjorth IMD, Kristensen SG, Gallos I, and Coomarasamy A
- Published
- 2022
- Full Text
- View/download PDF
37. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.
- Author
-
Khattak H, Malhas R, Craciunas L, Afifi Y, Amorim CA, Fishel S, Silber S, Gook D, Demeestere I, Bystrova O, Lisyanskaya A, Manikhas G, Lotz L, Dittrich R, Colmorn LB, Macklon KT, Hjorth IMD, Kristensen SG, Gallos I, and Coomarasamy A
- Subjects
- Cryopreservation, Estrogens, Female, Follicle Stimulating Hormone, Humans, Live Birth, Ovary, Pregnancy, Abortion, Spontaneous, Fertility Preservation methods
- Abstract
Background: Ovarian tissue cryopreservation involves freezing and storing of surgically retrieved ovarian tissue in liquid or vapour nitrogen below -190°C. The tissue can be thawed and transplanted back with the aim of restoring fertility or ovarian endocrine function. The techniques for human ovarian tissue freezing and transplantation have evolved over the last 20 years, particularly in the context of fertility preservation in pre-pubertal cancer patients. Fresh ovarian tissue transplantation, using an autograft or donor tissue, is a more recent development; it has the potential to preserve fertility and hormonal function in women who have their ovaries removed for benign gynaecological conditions. The techniques of ovarian tissue cryopreservation and transplantation have progressed rapidly since inception; however, the evidence on the success of this intervention is largely based on case reports and case series., Objective and Rationale: The aim of this study was to systematically review the current evidence by incorporating study-level and individual patient-level meta-analyses of women who received ovarian transplants, including frozen-thawed transplant, fresh or donor graft., Search Methods: The review protocol was registered with PROSPERO (CRD42018115233). A comprehensive literature search was performed using MEDLINE, EMBASE, CINAHL and Cochrane Central Register of Controlled Trials from database inception to October 2020. Authors were also contacted for individual patient data if relevant outcomes were not reported in the published manuscripts. Meta-analysis was performed using inverse-variance weighting to calculate summary estimates using a fixed-effects model., Outcomes: The review included 87 studies (735 women). Twenty studies reported on ≥5 cases of ovarian transplants and were included in the meta-analysis (568 women). Fertility outcomes included pregnancy, live birth and miscarriage rates, and endocrine outcomes included oestrogen, FSH and LH levels. The pooled rates were 37% (95% CI: 32-43%) for pregnancy, 28% (95% CI: 24-34%) for live birth and 37% (95% CI: 30-46%) for miscarriage following frozen ovarian tissue transplantation. Pooled mean for pre-transplant oestrogen was 101.6 pmol/l (95% CI: 47.9-155.3), which increased post-transplant to 522.4 pmol/l (95% CI: 315.4-729; mean difference: 228.24; 95% CI: 180.5-276). Pooled mean of pre-transplant FSH was 66.4 IU/l (95% CI: 52.8-84), which decreased post-transplant to 14.1 IU/l (95% CI: 10.9-17.3; mean difference 61.8; 95% CI: 57-66.6). The median time to return of FSH to a value <25 IU/l was 19 weeks (interquartile range: 15-26 weeks; range: 0.4-208 weeks). The median duration of graft function was 2.5 years (interquartile range: 1.4-3.4 years; range: 0.7-5 years). The analysis demonstrated that ovarian tissue cryopreservation and transplantation could restore reproductive and hormonal functions in women. Further studies with larger samples of well-characterized populations are required to define the optimal retrieval, cryopreservation and transplantation processes., Wider Implications: Ovarian tissue cryopreservation and transplantation may not only be effective in restoring fertility but also the return of reproductive endocrine function. Although this technology was developed as a fertility preservation option, it may have the scope to be considered for endocrine function preservation., (© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
38. Why are women considering ovarian tissue cryopreservation to preserve reproductive and hormonal ovarian function? A qualitative study protocol.
- Author
-
Khattak H, Gallos I, Coomarasamy A, and Topping AE
- Subjects
- Cryopreservation methods, Female, Humans, Ovary, Pregnancy, Reproduction, Fertility Preservation methods, Neoplasms therapy
- Abstract
Introduction: Current fertility preservation options available to women are oocyte cryopreservation (egg freezing) or embryo cryopreservation. A newer procedure, ovarian tissue cryopreservation (OTC), has become available in some centres, which offers another option for women and girls considering fertility preservation. These procedures are commonly offered to women about to undergo treatments for cancer. OTC involves removing sections of ovarian tissue and cryopreserving it for future reimplantation, often several years later. OTC offers girls and women who may become infertile with optionality and the possibility of pregnancy. OTC has potential for other applications, including restoring ovarian endocrine function beyond biological menopause. This is not without controversy but has led to some women considering undergoing the procedure for purposes of ovarian hormonal preservation (conservation of ovarian endocrine function). OTC is invasive, involves two surgical procedures with concomitant risks and can be costly. Understanding why women may consider and ultimately undergo OTC is timely, so that evidence-based and women-centred care can be provided., Methods: A pragmatic narrative qualitative design will be used. A purposive sample of women aged 18-45 who are considering, or have sought, OTC will be recruited over 1-year period. Potential participants will be approached via a clinic that offers OTC on a private basis or via social media., Analysis: Participant interviews will be audio and, if consented, video recorded. These will be conducted face-to-face or virtually. The recordings will be transcribed verbatim and analysed using a thematic analysis approach supported by NVivo software., Ethics and Dissemination: Ethical approval has been granted by the Institutional Ethical Review ERN_19-1578A. We expect to disseminate the findings of this study through journal articles, conference presentations and multimedia to public., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
39. Influence of COVID-19 on the Tourism Industry in China: An Artificial Neural Networks Approach.
- Author
-
Waleed, Ma Z, Wahid F, Baseer S, AlZubi AA, and Khattak H
- Subjects
- China epidemiology, Humans, Neural Networks, Computer, Reproducibility of Results, Tourism, COVID-19 epidemiology
- Abstract
Prior to COVID-19, the tourism industry was one of the important sectors of the world economy. This study intends to measure the perception of Chinese tourists concerning the spread of COVID-19 in China. The crowding perception, xenophobia, and ethnocentrism are the measurement indicators of the study. A five-point Likert scale is used to predict the perception of the tourists in various destinations. The Kaiser-Mayer-Olkin test and Cronbach's alpha are conducted to ensure the validity and reliability of the corresponding items. SPSS version 21 is used to obtain factor loading, mean values, and standard deviation. Regression analysis is used to measure the strength of the constructs' relationship and prove the hypotheses. Questionnaires have been filled from 730 Chinese respondents. Artificial neural networks and confusion matrices are used for validation and performance evaluation, respectively. Results show that crowding perception, xenophobia, and ethnocentrism caused the spread of COVID-19 during the epidemic. Hence, the tourism industry in China is adversely affected by COVID-19. The crisis management stakeholders of the country need to adopt policies to reduce the spread of COVID-19. The tourism sector needs to provide confidence to the tourists. It will provide ground for the mental strength of the tourists in China., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2022 Waleed et al.)
- Published
- 2022
- Full Text
- View/download PDF
40. Intelligent Malaysian Sign Language Translation System Using Convolutional-Based Attention Module with Residual Network.
- Author
-
Khan RU, Khattak H, Wong WS, AlSalman H, Mosleh MAA, and Mizanur Rahman SM
- Subjects
- Attention, Computer Systems, Humans, Neural Networks, Computer, Sign Language, Translations
- Abstract
The deaf-mutes population always feels helpless when they are not understood by others and vice versa. This is a big humanitarian problem and needs localised solution. To solve this problem, this study implements a convolutional neural network (CNN), convolutional-based attention module (CBAM) to recognise Malaysian Sign Language (MSL) from images. Two different experiments were conducted for MSL signs, using CBAM-2DResNet (2-Dimensional Residual Network) implementing "Within Blocks" and "Before Classifier" methods. Various metrics such as the accuracy, loss, precision, recall, F 1-score, confusion matrix, and training time are recorded to evaluate the models' efficiency. The experimental results showed that CBAM-ResNet models achieved a good performance in MSL signs recognition tasks, with accuracy rates of over 90% through a little of variations. The CBAM-ResNet "Before Classifier" models are more efficient than "Within Blocks" CBAM-ResNet models. Thus, the best trained model of CBAM-2DResNet is chosen to develop a real-time sign recognition system for translating from sign language to text and from text to sign language in an easy way of communication between deaf-mutes and other people. All experiment results indicated that the "Before Classifier" of CBAMResNet models is more efficient in recognising MSL and it is worth for future research., Competing Interests: The authors declare that they have no conflicts of interest to report regarding the present study., (Copyright © 2021 Rehman Ullah Khan et al.)
- Published
- 2021
- Full Text
- View/download PDF
41. Secure Patient Authentication Framework in the Healthcare System Using Wireless Medical Sensor Networks.
- Author
-
Jan SU, Ali S, Abbasi IA, Mosleh MAA, Alsanad A, and Khattak H
- Subjects
- Computer Communication Networks, Confidentiality, Delivery of Health Care, Humans, Computer Security, Internet of Things
- Abstract
Biosensor is a means to transmit some physical phenomena, like body temperature, pulse, respiratory rate, electroencephalogram (EEG), electrocardiogram (ECG), and blood pressure. Such transmission is performed via Wireless Medical Sensor Network (WMSN) while diagnosing patients remotely through Internet-of-Medical-Things (IoMT). The sensitive data transmitted through WMSN from IoMT over an insecure channel is vulnerable to several threats and needs proper attention to be secured from adversaries. In contrast to addressing the security of all associated entities involving patient monitoring in the healthcare system or ensuring the integrity, authorization, and nonrepudiation of information over the communication line, no one can guarantee its security without a robust authentication protocol. Therefore, we have proposed a lightweight and robust authentication scheme for the network-enabled healthcare devices (IoMT) that mitigate all the identified weaknesses posed in the recent literature. The proposed protocol's security has been analyzed formally using BAN logic and ProVerif2.02 and informally using pragmatic illustration. Simultaneously, at the end of the paper, the performance analysis result shows a delicate balance of security with performance that is often missing in the current protocols., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2021 Saeed Ullah Jan et al.)
- Published
- 2021
- Full Text
- View/download PDF
42. The influence of the COVID-19 outbreak on European trainees in obstetrics and gynaecology: A survey of the impact on training and trainee.
- Author
-
Boekhorst F, Khattak H, Topcu EG, Horala A, and Gonçalves Henriques M
- Subjects
- Cross-Sectional Studies, Europe epidemiology, Female, Humans, Pandemics, Pregnancy, SARS-CoV-2, Surveys and Questionnaires, COVID-19, Gynecology, Obstetrics
- Abstract
Objective: The purpose of this study is to evaluate how the obstetrics and gynaecology residency program and trainees have been affected by the Corona Virus Disease-19 (COVID-19) pandemic in Europe., Study Design: This study is a cross-sectional explorative survey using an online questionnaire. The questionnaire comprised of 40 questions that were subdivided into 4 subjects; workload, specialist training aspects in obstetrics and gynaecology, health and safety of the trainee and women's health and maternal health issues. Inclusion criteria consisted of being a trainee in Obstetrics and Gynaecology (ObGyn) at the time of the COVID-19 pandemic in Europe or trainees who had recently finished their training during the time of the outbreak. Taking part in the survey was voluntary. The questionnaire was shared on the website of the European Network for Trainees in Obstetrics and Gynaecology (ENTOG), ENTOG social media, in the ENTOG-newsletter and through the national representatives of ENTOG., Results: 110 ObGyn trainees from 25 different countries responded to the questionnaire. Almost all trainees (95 %, N = 105) reported an effect on their training due to COVID-19 pandemic. Training was interrupted in 21 % of cases (n = 23). Trainees observed a decrease in educational activities or lectures and a decrease in number of patients. The possibility of training surgical skills decreased, because 67 % (N = 74) trainees reported that surgeries were cancelled. Trainees expressed concerns about reaching the goals of their ObGyn specialist training in 60 % (n = 66) of cases. A decrease in workload was experienced during the first COVID-19 wave in Europe by 60 % (n = 66) of trainees. On average these trainees worked 33 % less hours compared to a normal workweek. Although 22 % (n = 24) were expected to be available continuously for 24 h a day and 7 days a week for unscheduled duties, 15 % (n = 16) were deployed to work on special COVID-units. Concerning preparation, 45 % of the trainees (n = 50) had not received any training for treating COVID-positive patients. Trainees claimed to have enough personal protective equipment (PPE), although problems were reported. Any form of psychosocial support was arranged for 65 % of trainees (n = 71) by the hospital or department. The results of the survey suggest that obstetric care was not affected much (92 % (n = 102) of the respondents said at least necessary care continued) while patients in need for reproductive medicine were affected the most; out of the 110 departments 58 % (n = 60) were closed and 35 % (n = 36) reduced their activities. Access to family planning and benign gynaecology were also significantly reduced; 77 % and 87 % respectively of the departments were less accessible or only open to emergency cases., Conclusion: COVID-19 pandemic has had a tremendous effect on the ObGyn training in Europe. Exposure to learning opportunities, surgeries and teaching has been decreased during the outbreak and may result in a decrease in quality of care provided to women in the future if impairment of training is not recovered., Competing Interests: Declaration of Competing Interest None., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
43. An Efficient and Provable Secure Certificate-Based Combined Signature, Encryption and Signcryption Scheme for Internet of Things (IoT) in Mobile Health (M-Health) System.
- Author
-
Ullah I, Amin NU, Khan MA, Khattak H, and Kumari S
- Subjects
- Algorithms, Computer Security, Confidentiality, Humans, Internet of Things, Telemedicine
- Abstract
Mobile health (M-Health) system is the remote form of Wireless Body Area Networks (WBAN), which can be used for collecting patient's health data in real-time with mobile devices, and storing it to the network servers. The data can be accessed by doctors to monitor, diagnosed and treat patients through a variety of techniques and technologies. The main advantage of the M-Health system is the ease of time-independent communication from physically distant places that enhances the quality of healthcare services at a reduced cost. Furthermore, to provide faster access to the treatment of patients, an M-Health system can be integrated with the internet of things (IoT) to offer preventive or proactive healthcare services by connecting devices and persons. However, its equally great drawback lies in transmitting and receiving the health information wirelessly through an open wireless medium that offers different security and privacy violation threats. We aim to address such a deficiency, and thus a new scheme called an efficient and provable secure certificate-based combined signature, encryption and signcryption (CBCSES) scheme, has been proposed in this article. The scheme not only obtains encryption and signcryption but also provides encryption or signature model alone when needed. To show the effectiveness of the proposed scheme, detailed security analyses, i.e. indistinguishable under adaptive chosen-ciphertext attacks (IND-CBCSES-CCA) and unforgeable under adaptive chosen message attacks (EUF-CBCSES-CMA), and the comparisons with relevant existing schemes are carried out. The results obtained authenticate the superiority of our scheme in terms of both computation and communication costs with enhanced security.
- Published
- 2020
- Full Text
- View/download PDF
44. Comparison of transcatheter aortic valve replacement risk score against currently accepted surgical risk models as predictors of 30-day mortality in transcatheter aortic valve replacement.
- Author
-
Yatsynovich Y, Khattak H, Ali M, Schwartz B, Pak S, and Chen T
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Assessment methods, Transcatheter Aortic Valve Replacement mortality
- Abstract
Objectives: Aim of the study was to assess the predictive capability of Transcatheter Aortic Valve Replacement Risk Score (TAVR-RS) in comparison with Society of Thoracic Surgeon-Predicted Risk of Mortality (STS PROM) and European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) on 30-day mortality following TAVR., Background: With exponentially increasing use of TAVR, a risk stratification model to accurately predict mortality risks in patients undergoing TAVR is urgently warranted., Methods: Retrospective analysis of 182 TAVRs between 2014 and 2017, 179 by transfemoral, 3 by subclavian approach. Clinical, laboratory and echocardiography variables were collected. The performance of risk models was evaluated using equivalence tests, receiver operating characteristic (ROC) and area under the ROC curve (AUC). Outcome was 30-day mortality prediction., Results: Observed 30-day mortality was 5.49%. TAVR-RS underestimated (4.0%) while surgical models (STS PROM and EuroSCORE II) overestimated mortality, 7.24% and 8.14%, respectively. The TAVR-RS was found to have statistically significant correlation with both individual and group mortalities. AUC was highest for TAVR-RS 0.66 (95%CI: 0.31-0.96), but no difference in 30-day mortality prediction was found in comparison with STS PROM (P = 0.06) or EuroSCORE II (P = 0.2161)., Conclusions: The TAVR-RS was a better predictor of both group and individual mortality at 30 days. The outcomes were comparable on pairwise testing against surgical risk models, although TAVR-RS was on verge of significance when compared to STS PROM. This study supports the current dogma that a risk model specifically tailored for TAVR population should be implemented to obtain a better patient selection., (© 2017, Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
45. Three Anomalies and a Complication: Ruptured Noncoronary Sinus of Valsalva Aneurysm, Atrial Septal Aneurysm, and Patent Foramen Ovale.
- Author
-
Khattak H, Patel A, Al-Zubaidi M, and Tivakaran V
- Abstract
The confluence of atrial septal aneurysm and patent foramen ovale in noncoronary sinus of Valsalva has not been previously documented in the literature., Competing Interests: Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
- Published
- 2017
46. Atrial Papillary Fibroelastoma: A Stranger in a Strange Place.
- Author
-
Haider I, Kawsar H, Khattak H, and Siddiqui M
- Abstract
Papillary fibroelastoma (PFE) is the most common primary tumor of cardiac valves and predominantly located on the left side. Its origin from non-valvular endocardium is extremely rare. We describe a case of an 81-year-old Caucasian male who presented with a mobile right atrial mass at the junction of right atrial wall and superior vena cava (SVC). Initially it was thought to be a thrombus and the patient was treated with anti-coagulation therapy without any change in size of the mass. Surgical excision was performed to establish the diagnosis and histopathology confirmed the diagnosis of PFE. In conclusion, this case is unique due to location of the tumor and its attachment with superior vena cava. Physicians should consider this unusual location of PFE in the differential diagnoses of an intra-atrial mass.
- Published
- 2015
- Full Text
- View/download PDF
47. Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.
- Author
-
Joseph SM, Novak E, Arnold SV, Jones PG, Khattak H, Platts AE, Dávila-Román VG, Mann DL, and Spertus JA
- Subjects
- Disease Progression, Female, Follow-Up Studies, Heart Failure diagnosis, Heart Failure physiopathology, Humans, Incidence, Male, Middle Aged, Prognosis, Prospective Studies, Quality of Life, Reproducibility of Results, Severity of Illness Index, United States epidemiology, Health Status, Heart Failure epidemiology, Stroke Volume, Surveys and Questionnaires
- Abstract
Background: Despite the growing epidemic of heart failure with preserved ejection fraction (HFpEF), no valid measure of patients' health status (symptoms, function, and quality of life) exists. We evaluated the Kansas City Cardiomyopathy Questionnaire (KCCQ), a validated measure of HF with reduced EF, in patients with HFpEF., Methods and Results: Using a prospective HF registry, we dichotomized patients into HF with reduced EF (EF≤ 40) and HFpEF (EF≥50). The associations between New York Heart Association class, a commonly used criterion standard, and KCCQ Overall Summary and Total Symptom domains were evaluated using Spearman correlations and 2-way ANOVA with differences between patients with HF with reduced EF and HFpEF tested with interaction terms. Predictive validity of the KCCQ Overall Summary scores was assessed with Kaplan-Meier curves for death and all-cause hospitalization. Covariate adjustment was made using Cox proportional hazards models. Internal reliability was assessed with Cronbach's α. Among 849 patients, 200 (24%) had HFpEF. KCCQ summary scores were strongly associated with New York Heart Association class in both patients with HFpEF (r=-0.62; P<0.001) and HF with reduced EF (r=-0.55; P=0.27 for interaction). One-year event-free rates by KCCQ category among patients with HFpEF were 0 to 25=13.8%, 26 to 50=59.1%, 51 to 75=73.8%, and 76 to 100=77.8% (log rank P<0.001), with no significant interaction by EF (P=0.37). The KCCQ domains demonstrated high internal consistency among patients with HFpEF (Cronbach's α=0.96 for overall summary and ≥0.69 in all subdomains)., Conclusions: Among patients with HFpEF, the KCCQ seems to be a valid and reliable measure of health status and offers excellent prognostic ability. Future studies should extend and replicate our findings, including the establishment of its responsiveness to clinical change.
- Published
- 2013
- Full Text
- View/download PDF
48. Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.
- Author
-
Kezerashvili A, Khattak H, Barsky A, Nazari R, and Fisher JD
- Subjects
- Bradycardia therapy, Female, Humans, Middle Aged, Pacemaker, Artificial, Anti-Bacterial Agents adverse effects, Azithromycin adverse effects, Long QT Syndrome chemically induced, Torsades de Pointes chemically induced
- Abstract
During treatment with azithromycin, a 55 year-old woman developed a newly prolonged QT interval and torsade de pointes in the absence of known risk factors. Female gender and acute renal failure may be considerations in patients treated with azithromycin.
- Published
- 2007
- Full Text
- View/download PDF
49. Case study: delirium in an adolescent girl with human immunodeficiency virus-associated dementia.
- Author
-
Scharko AM, Baker EH, Kothari P, Khattak H, and Lancaster D
- Subjects
- AIDS Dementia Complex pathology, Adolescent, Antipsychotic Agents therapeutic use, Brain pathology, Citalopram therapeutic use, Delirium drug therapy, Drug Therapy, Combination, Female, Humans, Magnetic Resonance Imaging, Neurologic Examination, Risperidone therapeutic use, AIDS Dementia Complex psychology, Delirium diagnosis, Delirium etiology
- Abstract
Delirium and human immunodeficiency virus (HIV)-associated dementia are well recognized neuropsychiatric consequences of HIV infection in adults. Almost nothing is known regarding the management of delirium in HIV-infected children and adolescents. HIV-related progressive encephalopathy is thought to represent the pediatric form of HIV-associated dementia; however, this condition occurs in HIV-infected infants and preschool children and is rapidly followed by death. This report describes the identification and treatment of apparent HIV-associated dementia complicated by delirium in an adolescent girl.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.